New Results
NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune response
Teresa R. Wagner, Philipp D. Kaiser, Marius Gramlich, View ORCID ProfileMatthias Becker, Bjoern Traenkle, Daniel Junker, Julia Haering, Alex Dulovic, Helen Schweizer, Stefan Nueske, Armin Scholz, Anne Zeck, Katja Schenke-Layland, Annika Nelde, Monika Strengert, Juliane S. Walz, Natalia Ruetalo, Michael Schindler, View ORCID ProfileNicole Schneiderhan-Marra, View ORCID ProfileUlrich Rothbauer
doi: https://doi.org/10.1101/2020.09.22.308338
Teresa R. Wagner
1Pharmaceutical Biotechnology, Eberhard Karls University Tuebingen, Germany
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Philipp D. Kaiser
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Marius Gramlich
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Matthias Becker
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Bjoern Traenkle
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Daniel Junker
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Julia Haering
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Alex Dulovic
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Helen Schweizer
3Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany
Stefan Nueske
3Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany
Armin Scholz
3Livestock Center of the Faculty of Veterinary Medicine, Ludwig Maximilians University Munich, Oberschleissheim, Germany
Anne Zeck
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Katja Schenke-Layland
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
4Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
6Department of Women’s Health, Research Institute for Womens’s Health, Eberhard-Karls-University, Tuebingen, Germany
7Department of Medicine/Cardiology, Cardiovascular Research Laboratories, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
Annika Nelde
4Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
8Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
9Institute for Cell Biology, Department of Immunology, University of Tuebingen, Tuebingen, Germany
Monika Strengert
11Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany
12TWINCORE GmbH, Centre for Experimental and Clinical Infection Research, a joint venture of the Hannover Medical School and the Helmholtz Centre for Infection Research, Hannover, Germany
Juliane S. Walz
4Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
8Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK), Department of Internal Medicine, University Hospital Tuebingen, Tuebingen, Germany
9Institute for Cell Biology, Department of Immunology, University of Tuebingen, Tuebingen, Germany
10Department of Hematology, Oncology, Clinical Immunology and Rheumatology, University Hospital Tuebingen, Tuebingen, Germany
Natalia Ruetalo
5Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital, Tuebingen, Germany
Michael Schindler
5Institute for Medical Virology and Epidemiology of Viral Diseases, University Hospital, Tuebingen, Germany
Nicole Schneiderhan-Marra
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
Ulrich Rothbauer
1Pharmaceutical Biotechnology, Eberhard Karls University Tuebingen, Germany
2Natural and Medical Sciences Institute at the University of Tuebingen, Germany
4Cluster of Excellence iFIT (EXC2180) “Image-Guided and Functionally Instructed Tumor Therapies”, University of Tuebingen, Tuebingen, Germany
Posted September 28, 2020.
NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune response
Teresa R. Wagner, Philipp D. Kaiser, Marius Gramlich, Matthias Becker, Bjoern Traenkle, Daniel Junker, Julia Haering, Alex Dulovic, Helen Schweizer, Stefan Nueske, Armin Scholz, Anne Zeck, Katja Schenke-Layland, Annika Nelde, Monika Strengert, Juliane S. Walz, Natalia Ruetalo, Michael Schindler, Nicole Schneiderhan-Marra, Ulrich Rothbauer
bioRxiv 2020.09.22.308338; doi: https://doi.org/10.1101/2020.09.22.308338
NeutrobodyPlex - Nanobodies to monitor a SARS-CoV-2 neutralizing immune response
Teresa R. Wagner, Philipp D. Kaiser, Marius Gramlich, Matthias Becker, Bjoern Traenkle, Daniel Junker, Julia Haering, Alex Dulovic, Helen Schweizer, Stefan Nueske, Armin Scholz, Anne Zeck, Katja Schenke-Layland, Annika Nelde, Monika Strengert, Juliane S. Walz, Natalia Ruetalo, Michael Schindler, Nicole Schneiderhan-Marra, Ulrich Rothbauer
bioRxiv 2020.09.22.308338; doi: https://doi.org/10.1101/2020.09.22.308338
Subject Area
Subject Areas
- Biochemistry (11690)
- Bioengineering (8712)
- Bioinformatics (29101)
- Biophysics (14916)
- Cancer Biology (12045)
- Cell Biology (17335)
- Clinical Trials (138)
- Developmental Biology (9403)
- Ecology (14130)
- Epidemiology (2067)
- Evolutionary Biology (18252)
- Genetics (12209)
- Genomics (16747)
- Immunology (11835)
- Microbiology (27971)
- Molecular Biology (11536)
- Neuroscience (60742)
- Paleontology (450)
- Pathology (1864)
- Pharmacology and Toxicology (3224)
- Physiology (4933)
- Plant Biology (10376)
- Synthetic Biology (2875)
- Systems Biology (7326)
- Zoology (1640)